Holen Sie sich die Stockscreener-App
7.31
1.75%
-0.13
Schlusskurs vom Vortag:
$7.44
Offen:
$7.36
24-Stunden-Volumen:
1.69M
Relative Volume:
1.10
Marktkapitalisierung:
$748.78M
Einnahmen:
$187.64M
Nettoeinkommen (Verlust:
$-95.00M
KGV:
-7.6947
EPS:
-0.95
Netto-Cashflow:
$-69.02M
1W Leistung:
-2.53%
1M Leistung:
-8.05%
6M Leistung:
-7.82%
1J Leistung:
-50.10%
1-Tages-Spanne:
$7.235
$7.62
1-Wochen-Bereich:
$6.90
$7.62
52-Wochen-Spanne:
$5.635
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
Firmenname
Day One Biopharmaceuticals Inc
Sektor
Branche
Telefon
650 484-0899
Adresse
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
Vergleichen Sie DAWN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
7.31 | 762.09M | 187.64M | -95.00M | -69.02M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-10-09 | Bestätigt | Needham | Buy |
| 2024-08-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-04-24 | Bestätigt | Needham | Buy |
| 2023-04-25 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-08 | Eingeleitet | CapitalOne | Overweight |
| 2023-02-03 | Eingeleitet | Oppenheimer | Perform |
| 2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-12-05 | Eingeleitet | Goldman | Buy |
| 2022-12-01 | Eingeleitet | BofA Securities | Buy |
Alle ansehen
Day One Biopharmaceuticals Inc Aktie (DAWN) Neueste Nachrichten
Pattern recognition hints at Day One Biopharmaceuticals Inc. upsideBull Run & Weekly High Potential Stock Alerts - newser.com
Multi factor analysis applied to Day One Biopharmaceuticals Inc.Insider Selling & Weekly Return Optimization Plans - newser.com
Day One Biopharmaceuticals Inc (DAWN) Q3 2025 Earnings Report Pr - GuruFocus
Day One Biopharmaceuticals Inc (DAWN) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Will Day One Biopharmaceuticals Inc. stock remain a Wall Street favoriteEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Key resistance and support levels for Day One Biopharmaceuticals Inc.Weekly Trade Report & Community Shared Stock Ideas - newser.com
Will Day One Biopharmaceuticals Inc. stock maintain growth storyJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com
Market reaction to Day One Biopharmaceuticals Inc.’s recent news2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - newser.com
What Wall Street predicts for Day One Biopharmaceuticals Inc. stock priceJuly 2025 Summary & Technical Pattern Based Buy Signals - newser.com
How Day One Biopharmaceuticals Inc. stock benefits from global expansionForecast Cut & Advanced Technical Analysis Signals - newser.com
Will Day One Biopharmaceuticals Inc. price bounce be sustainableEarnings Overview Report & Community Consensus Stock Picks - newser.com
Will Day One Biopharmaceuticals Inc. stock recover faster than peersWeekly Investment Summary & Stock Timing and Entry Methods - newser.com
Y Intercept Hong Kong Ltd Invests $1.83 Million in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
What Fibonacci levels say about Day One Biopharmaceuticals Inc. reboundJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com
Applying Wyckoff theory to Day One Biopharmaceuticals Inc. stockJuly 2025 Retail & Capital Efficiency Focused Ideas - newser.com
Day One Biopharmaceuticals Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView
Day One Biopharmaceuticals (NASDAQ:DAWN) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Day One Biopharmaceuticals Inc. stock outlook for YEARJuly 2025 Price Swings & Advanced Technical Analysis Signals - newser.com
Why Day One Biopharmaceuticals Inc. stock attracts global investors2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
What does recent volatility data suggest for Day One Biopharmaceuticals Inc.Volume Spike & Verified Chart Pattern Signals - newser.com
Forecasting Day One Biopharmaceuticals Inc. price range with options data2025 Volatility Report & Weekly Top Gainers Trade List - newser.com
Wall Street Analysts See a 234.66% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High? - sharewise.com
Day One Biopharmaceuticals Advances Cancer Treatment with DAY301 Study - MSN
Can Day One Biopharmaceuticals Inc. rally from current levels2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):